Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Read on for a clear and honest answer
Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
Peptides help your body rebuild from within
The collagen that forms creates smoother, more natural-appearing tissue
Enhanced cognitive function
US$ 21.35
US$ 25.60
US$ 25.57
US$ 27.65
